• EASY HOME

    TESTING FOR

    PEACE OF MIND

    Simple and Convenient Home Testing for Lyme Disease.

    For early bird pricing and product updates, enter your contact details.

    Image for illustration purposes only.

  • Saving you Time and Worry

    We are an MIT startup working on an at-home Lyme disease test kit, using cutting-edge, patent-pending nanotechnology to quickly identify if a tick carries Lyme disease, by detecting the presence of the Borrelia burgdorferi bacterium, the culprit behind Lyme disease.

     

    With this groundbreaking innovation, you can swiftly and confidently check ticks found on you or your pet's body for potential infection, all from the comfort of your home.

     

    Our Lyme disease screening kit delivers rapid results and tests for Lyme disease, even if the disease is in its early stages. Early detection is crucial when it comes to Lyme disease, and our kit empowers you with the knowledge to take swift action.

  • Find Out More

    Watch our pitch at Demo Day for MIT's delta v accelerator program, to learn more about the problem we are solving, our Vision and our Product.

  • Cutting Edge Technology for a Peace of Mind

    < 30 mins

    Test Time

    (vs. days for mail-in tests)

    > 95%

    Specificity

    (Using a Gold standard test method)

  • broken image

    Revolutionizing Lyme Disease Screening

    Say goodbye to the hassle of mailing ticks or blood samples to a distant lab and the uncertainty of lengthy processing times to get your results. With our at-home screening kit, you’re in control.

  • broken image

    Empowering you to make informed decisions

    Our mission is simple: to increase accessibility to Lyme disease screening, for a quick and accurate diagnosis. Whether your screening result is positive or negative, you gain the knowledge you need to make informed decisions about your health.

  • Our Vision of a Lyme-free World

    At LymeAlert, our Mission is to improve access to medical care through home testing. This will speed up the time-to-diagnosis, reduce unnecessary antibiotic use and aid global disease surveillance.

     

  • Supported by

    broken image
    broken image
    broken image